Turchia, Istanbul
Prof. Sezer Sağlam
Genetic tumor profiling with NGS technology guides personalized chemotherapy plans at Gayrettepe Florence Nightingale Hospital. Prof. Sezer Sağlam, nominated for an international research award, leads a comprehensive 5–7 day diagnostic phase for approximately $2,700. This initial session covers the hospital stay for patient and one companion, plus lab tests and imaging. Subsequent outpatient infusions are planned based on the genetic analysis results, with international patient support services available.